- Home
- TAIT vs CGTX Comparison
TAIT vs CGTX Comparison
Compare TAIT & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAIT
- CGTX
- Stock Information
- Founded
- TAIT 1989
- CGTX 2007
- Country
- TAIT United States
- CGTX United States
- Employees
- TAIT N/A
- CGTX N/A
- Industry
- TAIT Electronic Components
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- TAIT Technology
- CGTX Health Care
- Exchange
- TAIT Nasdaq
- CGTX Nasdaq
- Market Cap
- TAIT 16.0M
- CGTX 30.0M
- IPO Year
- TAIT 1995
- CGTX 2021
- Fundamental
- Price
- TAIT $2.66
- CGTX $0.63
- Analyst Decision
- TAIT
- CGTX Strong Buy
- Analyst Count
- TAIT 0
- CGTX 6
- Target Price
- TAIT N/A
- CGTX $8.30
- AVG Volume (30 Days)
- TAIT 9.3K
- CGTX 1.3M
- Earning Date
- TAIT 11-14-2024
- CGTX 03-25-2025
- Dividend Yield
- TAIT 7.69%
- CGTX N/A
- EPS Growth
- TAIT N/A
- CGTX N/A
- EPS
- TAIT 0.22
- CGTX N/A
- Revenue
- TAIT $4,343,000.00
- CGTX N/A
- Revenue This Year
- TAIT N/A
- CGTX N/A
- Revenue Next Year
- TAIT N/A
- CGTX N/A
- P/E Ratio
- TAIT $11.56
- CGTX N/A
- Revenue Growth
- TAIT N/A
- CGTX N/A
- 52 Week Low
- TAIT $2.52
- CGTX $0.34
- 52 Week High
- TAIT $3.34
- CGTX $2.95
- Technical
- Relative Strength Index (RSI)
- TAIT 57.50
- CGTX 41.97
- Support Level
- TAIT $2.52
- CGTX $0.70
- Resistance Level
- TAIT $2.65
- CGTX $0.82
- Average True Range (ATR)
- TAIT 0.05
- CGTX 0.06
- MACD
- TAIT 0.01
- CGTX -0.02
- Stochastic Oscillator
- TAIT 91.66
- CGTX 12.98
About TAIT Taitron Components Incorporated
Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.